On May 30, 2019 Replimune Group, Inc. (NASDAQ: REPL), a biotechnology company developing oncolytic immuno-gene therapies derived from its Immulytic platform, reported that members of its senior management team, will present and host investor meetings at the following two conferences (Press release, Replimune, MAY 30, 2019, View Source [SID1234536680]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Jefferies 2019 Global Healthcare Conference
Date: Wednesday, June 5, 2019
Presentation Time: 11:30 AM ET
Location: Grand Hyatt, New York, NY
BMO 2019 Prescriptions for Success Healthcare Conference
Date: Tuesday, June 25, 2019
Presentation Time: 11:40 AM ET
Location: Mandarin Oriental, New York, NY